EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)

Ever Fortune.AI, Co., Ltd. · K242821 · 2025-02-20

EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) is an AI-enabled medical device from Ever Fortune.AI, Co., Ltd., listed by FDA (510(k), K242821) with a decision date of 2025-02-20. Review panel: Radiology.

FDA submission numberK242821
Pathway510(k)
CompanyEver Fortune.AI, Co., Ltd.
Review panel (specialty)Radiology
FDA decision date2025-02-20
DecisionSubstantially Equivalent
Product codeQAS
ClassificationRadiological Computer-Assisted Triage And Notification Software
Device class2
Regulation number892.2080
Review time (calendar days)155
Applicant countryTW

Official FDA database record · FDA AI-enabled device list

More devices from Ever Fortune.AI, Co., Ltd. · All Radiology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.